Registration dossiers autorizados april 2010

R E G IS T R A T I O N D OS S I E R S A V A I L A B L E
RE TAI L MA RKE T (WHOL ESAL ER S AND PH ARM AC IES)
MOLECULE
REFERENCE PRODUCT

Acyclovir
Dexketoprofen
Solution for injection/Concentrate for solution for Doxazosin

Fluoxetine
Gabapentin
Glimepiride

Glucosamine Sulphate

Ibuprofen-lysine

Memantine
Mirtazapine
Pantoprazole
Quetiapine
Venlafaxine
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. R E G IS T R A T I O N D OS S I E R S A V A I L A B L E
HOSPI TA L MA RKE T
MOLECULE
REFERENCE PRODUCT

Acyclovir
Lyophilised powder for solution for infusion
Amoxicillin + clavulanic acid

Cefepime

Cefonicid
Powder and solvent for solution for injection
Cefotaxime
Powder and solvent for solution for injection Powder and solvent for solution for injection/infusion
Ceftazidime
Powder and solvent for solution for injection

Ceftriaxone
Powder and solvent for solution for injection

Cis-atracurium

2 mg/mL (5 mL and 10 mL), 5 mg/mL (30 mL)
Cefuroxime (Sodium)
Powder and solvent for solution for injection Powder for solution for injection/infusion Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. R E G IS T R A T I O N D OS S I E R S A V A I L A B L E
HOSPI TA L MA RKE T
MOLECULE
REFERENCE PRODUCT

Clindamycin
150 mg/ml (300 mg/2 ml, 600 mg/4 ml, 900 mg/6 ml)
Dexketoprofen

Solution for injection/Concentrate for solution for
Fluconazole

Flumazenil

Granisetron

Iron sucrose
Solution for injection/concentrate solution for infusion 20 mg/ml
Ketorolac Trometamol

Levofloxacin

Meropenem


Midazolam
1 mg/ml (5 mg/5 ml), 5 mg/ml (15 mg/3 ml and 50 mg/10 ml)
Pamidronate
Lyophilised powder for solution for infusion Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. April 2010 R E G IS T R A T I O N D OS S I E R S A V A I L A B L E
HOSPI TA L MA RKE T
MOLECULE
REFERENCE PRODUCT
Pantoprazole
Lyophilised powder for solution for injection/infusion
Paracetamol


Phenytoin

Piperacillin/Tazobactam
Lyophilised powder and solvent for solution for injection
Lyophilised powder for solution for injection
Remifentanil

Lyophilised powder for solution for injection/infusion Stilamin® (Serono, IT, NL, CH.) Somatostatin
Lyophilised powder and solvent for solution for infusion Modustatine® (Clin Midy, FR.)
Teicoplanina

Lyophilised powder and solvent for solution for injection
Vancomycin
Lyophilised powder for solution for injection
Zidovudine
Capsules

Zoledronic

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.

Source: http://combino-pharm.biz/upload/productos/PRODUCTOS%20INTERNACIONAL.pdf

12(1)

Andrade J C S Ávila Neto V Braile D M Brofman P R S Costa A R B Costa R Galvão Filho S S Gauch P R A Lucchese F AMartinelli Filho M Medeiros P T J Mateos J C P Pimenta J Takeda R T. Consenso Deca/SBCCV - 1999. Diretrizes para oImplante de Marcapasso Cardíaco Permanente. Reblampa 1999; 12(1): 1-9. Consenso Deca/SBCCV 1999 Diretrizes para o Implante de Cardioversor Desfibrilador Impla

© 2010-2017 Pharmacy Pills Pdf